Carbamazepine

Manufactured by Polpharma across three dedicated production lines with single impurities held below 0.06%, this Carbamazepine (CAS 298-46-4, Form III polymorph) is offered with EU DMF, CEP, Korean DMF, and US DMF readiness. As an anticonvulsant, it works by reducing the nerve impulses that cause seizures and nerve pain such as trigeminal neuralgia and diabetic neuropathy, and is also used to treat bipolar disorder. Samples are available, and the API is sold across North America, Europe, Australasia, Asia, the Middle East, and Africa; the supplier notes that in patent-protected markets such as Poland it is offered only to support regulatory submissions, not for open commercial sale.